Preview

Current Pediatrics

Advanced search

EFFECTIVENESS OF MOMETASONE FUROATE IN TREATMENT OF PALATINE TONSIL HYPERTROPHY IN CHILDREN

Abstract

Palatine tonsil hypertrophy is one of the most frequent cases of nasal obstruction in children. Perfection of conservative treatment of palatine tonsil hypertrophy is important direction in prophylaxis of inflammatory diseases of nasal cavity and paranasal sinuses. This article presents an experience of treatment with mometasone furoate (Nasonex) in children (n = 20) in age 6–15 years old with medium and severe nasal obstruction, caused by palatine tonsil hypertrophy. It was shown that treatment during 4 weeks, including mometasone furoate, resulted in increase of summary volumetric air flow rate, passing through the nasal cavity (from 304 ± 24 to 404 ± 22 sm3/s, p = 0.002), and decrease of summary resistance in fixed pressure point (from 0.64 ± 0.08 to 0.40 ± 0.02 Pa/sm3/s, p = 0.003). The degree of choanal obstruction was decreased at the time of study from 72% to 47%. Thus, treatment with mometasone furoate favors to reduction of volumetric size of palatine tonsil and reduction of endoscopic controlled choanal obstruction.
Key words: children, palatine tonsil hypertrophy, treatment, mometasone furoate.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(3):95-98)

About the Authors

E.V. Nosulya
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation


I.A. Kim
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation


References

1. Гаращенко Т.И., Ильенко Л.И., Смирнова Т.Н. и др. Гомо-токсикологические и гомеопатические препараты в комплексном лечении патологии носоглотки, дисфункции слуховой трубы и некоторых заболеваний уха, сопряженных с ней. Новости оториноларингологии и логопатологии. 1998; 2 (14): 47–50.

2. Быкова В.П., Бруевич О.А. и др. Аденоиды как индуктивный орган мукозального иммунитета верхних дыхательных путей. Российская ринология. 2005; 2: 175–176.

3. Balbani A.P., Weber S.A., Montovani J.C. Update in obstructive sleep apnea syndrome in children. Braz. J. Otorhinolaryngol. 2005; 71 (1): 74–80.

4. Goldbart A.D., Tal A. Inflammation and sleep disordered breathing in children: a state-of-the art review. Pediatr. Pulmonol. 2008; 43 (12): 1151–1160.

5. Hess M., Kugel J., Haake D. et. al. Reduced concentration of secretory IgA indicates of local immunity in children with adenoid hyperplasia and secretory otitis media. ORL. 1991; 53 (6): 339–341.

6. Быкова В.П. Лимфоэпителиальные органы в системе местного иммунитета слизистых оболочек. Арх. патологии. 1995; 1: 11–16.

7. Быкова В.П. Структурные основы мукозального иммунитета верхних дыхательных путей. Рос. ринология. 1999; 1: 5–9.

8. Modrzyński M., Mazurek H., Zawisza E. Allergic tonsillitis: myth or reality. Postepy Hig. Med. Dosw. (Online). 2005; 59: 450–456.

9. Modrzyński M., Zawisza E., Mazurek H. The influence of medical treatment of the perennial allergic rhinitis on the adenoid size in children. Otolaryngol. Pol. 2006; 60 (4): 543–550.

10. Shin K., Cho S., Kim K. et al. The role of adenoids in pediatric rhinosinusitis. Pediatr. Otorhinolaryngol. 2008; 72 (11): 1643–1650.

11. Tuncer U., Aydogan B. Soylu L. et al. Chronic rhinosinusitis and adenoid hypertrophy in children. Am. J. Otolaryngol. 2004; 25 (1): 5–10.

12. Ren Y., Isberg A., Henningsson G. Velopharyngeal incompetence and persistent hypernasality after adenoidectomy in children without palatal defect. Cleft. Palate Сraniofac. J. 1995; 32 (6): 476–482.

13. Pearl A.J., Manoukian J.J. Adenoidectomy: indirect visualization of choanal adenoids. J. Otolaryngol. 1994; 23 (3): 221–224.

14. Havas T., Lowinger D. Obstructive adenoid tissue: an indication for powered-shaver adenoidectomy. Arch. Otolaryngol. Head Neck Surg. 2002; 128 (7): 789–791.

15. Kheirandish-Gozal L., Serpero L., Dayyat E. et al. Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea. Eur. Respir. J. 2009; 35 (5) 1077-1084.

16. Berlucchi M., Salsi D., Valetti L. et.al. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Pediatrics. 2007; 119 (6): 1392–1397.


Review

For citations:


Nosulya E., Kim I. EFFECTIVENESS OF MOMETASONE FUROATE IN TREATMENT OF PALATINE TONSIL HYPERTROPHY IN CHILDREN. Current Pediatrics. 2009;8(3):95-98.

Views: 881


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)